Indirect comparison of remibrutinib and dupilumab in omalizumab-refractory chronic spontaneous urticaria

Journal of the American Academy of Dermatology 2026

View at publisher

Authors: Longmao Wu, Xiaomin Lin, Lin Li, Xianhua Tang

DOI: 10.1016/j.jaad.2026.04.2010

Cited by: 1

References: 4

Fields of Study & Subjects

Urticaria and Related Conditions Drug-Induced Adverse Reactions Autoimmune Bullous Skin Diseases

References 4